Clinical Trial Update: A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II clinical trial evaluating anecortave acetate for exudative age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• anecortave acetate (anecortave acetate)

Snippet

Sponsor: Alcon Research | Conditions: AMD | Phase 2 | Status: COMPLETED